Aeglea biotherapeutics, inc. (AGLE)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15
ASSETS
CURRENT ASSETS
Cash and cash equivalents

12,594

19,253

24,545

25,430

85,645

22,461

14,532

20,579

10,760

12,817

13,162

26,934

16,801

47,748

49,544

70,628

24,016

29,294

Marketable securities

36,398

52,696

64,155

80,111

-

52,052

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

38,070

-

50,203

51,614

32,715

37,482

42,587

36,459

41,067

15,754

18,491

2,947

4,970

3,768

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

155

80

80

Accounts receivable - grant

-

-

-

-

-

-

2,422

4,281

3,373

3,078

2,452

1,213

981

1,215

1,571

1,625

1,618

1,697

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,195

2,535

Prepaid expenses and other current assets

5,273

2,556

3,930

4,394

3,103

2,158

3,225

2,414

1,995

1,614

1,318

1,597

1,456

1,707

2,073

1,551

1,325

912

Total current assets

54,265

74,505

92,630

109,935

126,818

76,671

70,382

78,888

48,843

54,991

59,519

66,203

60,305

66,424

71,679

76,906

35,204

38,286

Restricted cash

1,500

1,500

1,500

1,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

4,244

2,385

980

921

952

1,018

846

776

810

854

844

802

822

599

342

377

321

348

Operating lease right-of-use assets

4,712

4,726

4,872

5,018

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current assets

60

67

114

120

749

50

49

49

133

232

139

139

140

40

40

18

18

20

TOTAL ASSETS

64,781

83,183

100,096

117,494

128,519

77,739

71,277

79,713

49,786

56,077

60,502

67,144

61,267

67,063

72,061

77,301

35,543

38,654

LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable

3,618

3,154

2,431

2,724

3,223

663

1,077

952

763

389

615

634

267

168

523

348

509

176

Operating lease liabilities

293

351

289

328

317

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

0

0

0

20

50

71

51

71

181

-

-

0

Accrued and other current liabilities

13,227

14,854

12,676

9,967

8,266

9,576

6,438

5,223

5,002

5,220

4,212

3,713

3,639

3,726

3,133

3,013

3,311

2,347

Total current liabilities

17,138

18,359

15,396

13,019

11,806

10,239

7,515

6,175

5,765

5,629

4,877

4,418

3,957

3,965

3,837

3,361

3,820

2,523

Non-current operating lease liabilities

4,815

4,712

4,867

4,815

372

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

23

31

38

45

52

72

81

91

101

111

117

122

127

132

26

16

22

27

TOTAL LIABILITIES

21,976

23,102

20,301

17,879

12,230

10,311

7,596

6,266

5,866

5,740

4,994

4,540

4,084

4,097

3,863

3,377

3,842

2,550

Commitments and Contingencies (Note 8)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of March 31, 2020 and December 31, 2019; no shares issued and outstanding as of March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

-

0

Common stock, $0.0001 par value; 500,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 29,147,461 shares and 29,084,437 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

3

3

3

3

3

2

2

2

2

2

2

2

1

1

1

1

0

-

Additional paid-in capital

256,779

255,142

253,334

251,592

-

184,314

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

250,301

-

165,675

163,547

124,648

122,950

121,568

120,787

108,743

108,246

107,988

107,478

1,513

1,373

Accumulated other comprehensive (loss) income

-134

51

78

67

13

-27

-33

-56

-98

-102

-32

-29

-37

-4

3

1

3

-1

Accumulated deficit

-213,800

-195,115

-173,600

-152,000

-134,028

-116,861

-101,963

-90,046

-80,632

-72,513

-66,030

-58,156

-51,524

-45,277

-39,794

-33,556

-28,126

-23,579

TOTAL STOCKHOLDERS’ EQUITY

42,805

60,081

79,795

99,615

116,289

67,428

63,681

73,447

43,920

50,337

55,508

62,604

57,183

62,966

68,198

73,924

-26,610

-22,207

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

64,781

83,183

100,096

117,494

128,519

77,739

71,277

79,713

49,786

56,077

60,502

67,144

61,267

67,063

72,061

77,301

35,543

38,654